Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure (M&M trial)
2017-002694-19Phase 4Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Pregnancy loss comparing Mifepristone + misoprostol with Misoprostol + placebo (2 arms). Primary endpoint: Complete uterine evacuation. Started Feb 2018; status: terminated.
02
Drugs
mifepristone
03
Conditions
Pregnancy loss
Beyond the preview
Go deeper on 2017-002694-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002694-19.